Vivos Therapeutics, Inc.

Private Placement Funds Operations as Vivos’ Medical Affiliation Model Begins to Take Hold LITTLETON, Colo., April 07, 2026 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and associated chronic health conditions, including obstructive sleep apnea...

Eli Lilly just agreed to pay up to $7.8 billion for a sleep-drug company with no approved products and years from commercialization—while a publicly traded company already treating thousands of patients with FDA-cleared solutions trades at roughly $11 million, highlighting a valuation gap that few investors in the sleep-health space are paying attention to.

Vivos CARE Oral Medical Devices Proven to Enhance Airways by Redeveloping Dental Arch Forms and Jaws LITTLETON, Colo., March 17, 2026 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing related sleep disorders and associated chronic health conditions, today...

Gregg C.E. Johnson, age 61, served as Secretary of the Company from July 2016 until July 2020, and a director of the Company from July 2016 until March 2018. Mr. Johnson received his Juris Doctorate degree in 1988 from Osgoode Hall Law School in Toronto, Canada, and was admitted as a lawyer in Alberta in...

Michael E. Bruhn is an accomplished senior healthcare executive with 29 years of extensive leadership experience across the public, private, and nonprofit sectors. He is currently the Executive Vice President, Business Operations Integration at Vivos Therapeutics, where he oversees and leads integration operations across all Vivos companies, supports corporate strategy development, and directs information systems...

SVP, Mergers and Acquisition Group Nick DeGennaro has served as our senior vice president of the medical integration division since October 2019. From September 2015 to July 2019, Mr. DeGennaro served as the director of business development and planning for Liberty Hospital, a community-based health system in Liberty, Missouri. From January 2015 to September 2015,...

Sr. Vice President, Product and Technology Todd Huntsman is a co-founder of our company and has served as the Senior Vice President – Manufacturing of our company since September 2016. Since November 2015, he has also served as the Senior Vice President – Manufacturing of First Vivos, Inc., which is now a wholly owned subsidiary...

Sr. Vice President RaeAnn Byrnes is a co-founder of our company and has served as senior vice president of people, training, and development since September 2016. Since November 2015, she has also served as the senior vice president of practice development of First Vivos, Inc., which is now a wholly owned subsidiary of our company....

EVP of Operations Susie McCullough is the Co‑Founder and Executive Vice President of Operations at Vivos Therapeutics, where she leads enterprise‑wide operational strategy focused on scaling the business, supporting multi‑state growth, and delivering consistent, measurable performance.With more than 43 years of experience in dental and healthcare operations, Susie brings deep expertise in building, scaling, and...